(Q40373834)

19 September 2017

1 reference

title

Recent advances in the application of gene therapy to human disease (English)

1 reference

19 September 2017

0 references

5

Champlin R

1 reference

19 September 2017

Hanania EG

1

1 reference

19 September 2017

Kavanagh J

2

1 reference

19 September 2017

Hortobagyi G

3

1 reference

19 September 2017

Giles RE

4

1 reference

19 September 2017

Deisseroth AB

6

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

American Journal of Medicine

19 September 2017

published in

1 reference

19 September 2017

volume

99

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

537-552

1 reference

Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Autologous bone marrow transplantation for CML in which retroviral markers are used to discriminate between relapse which arises from systemic disease remaining after preparative therapy versus relapse due to residual leukemia cells in autologous ma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Molecular analysis of retroviral transduction in chronic myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Selection of gene-marked tumor infiltrating lymphocytes from post-treatment biopsies: a case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Immunotherapy of malignancy by in vivo gene transfer into tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

The basic science of gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

7 January 2021

Lymphocyte gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Ribozymes as potential anti-HIV-1 therapeutic agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

The uptake and expression of the factor VIII and reporter genes by vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Gene transfer to brain using herpes simplex virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980232-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)80232-0

1 reference

19 September 2017

1 reference